| Line Item | 2022-02-28 | Y/Y |
|---|---|---|
| Revenue | $54K | -32.5% |
| R&D Expense | $537K | -46.5% |
| SG&A Expense | $344K | -25.8% |
| Operating Income | -$827K | +40.4% |
| Net Income | -$839K | +43.1% |
| Line Item | 2022-02-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $587 | -53.1% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $8K | -49.2% |
| Total Assets | $21K | -35.5% |
| Total Liabilities | $5.0M | +15.2% |
| Stockholders' Equity | -$5.0M | -15.6% |
| Line Item | 2022-02-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$405K | +4.6% |
| Capital Expenditures | $812 | -43.7% |
| Investing Cash Flow | -$812 | +43.7% |
| Financing Cash Flow | $401K | -8.0% |
| Free Cash Flow | -$406K | +4.7% |